Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Some hair loss drugs can cause a unique type of hair loss that resembles both psoriasis and alopecia.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.